Search results

Selected filters:

Life Sciences
News

Article type

Topic

Sector

Regions

Year

117 results found for your search

Sort options
24 August 2019

Adversaries no more - licensors look to make deals, not settlements

In its day, the IPNav model was hugely successful in generating cash, but successful licensing in the here and now requires a different, less confrontational approach

03 August 2019

Life sciences IP – the major developments in July

All the big pharma and biotech patent stories from last month in our regular monthly round-up

01 August 2019

Users like the EPO’s services - but there is still room to improve, according to new report

The annual assessment of the office’s performance finds that that satisfaction rates are up, but timeliness remains a problem

26 July 2019

Switzerland once again named as the world’s most innovative country

New research finds that Europe is ahead of the rest when it comes to the quality of innovations and also leads in filing international patents

18 July 2019

Federal Circuit decision shows door not shut on infringement claims under the doctrine of equivalents in ANDA cases

Ruling in UCB v Watson Laboratories provides important strategic guidance on the doctrine for both patent prosecutors and litigators

13 July 2019

<em>New York Times</em>’ seizure call shows how far the tide is turning against pharma IP

The newspaper’s controversial proposal is stark demonstration of the mounting patent pressure the life sciences sector is under in the US

10 July 2019

All the big life sciences IP developments in June

Our round-up of the major patent issues affecting pharma and biotech that emerged on the legal, market and policy fronts last month

09 July 2019

Incorrectly naming an RPI will not derail an IPR, Federal Circuit rules

In Mayne Pharma, the court upheld a PTAB final written decision invalidating a patent despite the owner’s objection that all real-parties-in-interest were not properly named in the original review petition

23 June 2019

Rubio’s Huawei proposal should worry US tech, pharma companies

Letting the executive branch neutralise patents whose owners it doesn’t like would weaken the US patent system and invite retaliation by China

19 June 2019

What to do with conflicting testimony on patent eligibility

Former CAFC Chief Judge Michel: “If the public debate is confused by unreliable statements of ill-informed or overzealous advocates, the US will decline and its future will fade.”

17 June 2019

IPBC Global 2019 – Day One highlights

All the big stories from the first full day of the world’s pre-eminent conference about IP value creation

17 June 2019

Why it's time for the world of patents to embrace diversity and gender equality

Special IAM boardroom session at IPBC Global 2019 focuses on how to get more women involved in senior positions in the global IP market - and why everyone will win when it happens

14 June 2019

“First do no harm” should be the guiding light of all attempts at patent reform

The current debate in the US around legislative changes to the eligible subject matter regime stands in marked contrast to the one triggered by the Innovation Act between 2013 and 2016

12 June 2019

IAM and sister publication GDR launch major data event

The Data Business Congress will take place in San Jose, CA, next February with the focus on the capture, protection, management, exploitation and monetisation of one of the pivotal assets of the 21st century